# Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584)

> **NCT00736242** · — · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 232 (actual)

## Conditions studied

- Chronic Hepatitis C
- Hepatitis C
- HIV Infections

## Interventions

- **BIOLOGICAL:** PEG-IFN alfa-2b
- **DRUG:** RBV

## Key facts

- **NCT ID:** NCT00736242
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 232 (ACTUAL)
- **Last updated:** 2015-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00736242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00736242, "Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00736242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*